Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | 1033 วันที่ผ่านมา
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

แท็ก : HOTH
read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 777 วันที่ผ่านมา
Sensex, Nifty Subdued In Lackluster Trade

Sensex, Nifty Subdued In Lackluster Trade

Indian shares were subdued on Tuesday as investors locked in some profits after recent gains, driven by optimism over easing global trade tensions and expectations of corporate earnings rebound.
RTTNews | 30 นาทีที่ผ่านมา
Australian Market Extends Early Losses In Mid-market

Australian Market Extends Early Losses In Mid-market

The Australian stock market is extending its early losses in mid-market trading on Tuesday, reversing the gains in the previous session, despite the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling well below the 9,050 level, with weakness across most sectors led by gold miners and technology stocks. Financial stocks are the only bright spot.
RTTNews | 1 ชม. 34 นาทีที่ผ่านมา
Asian Markets Mixed Amid Cautious Trades

Asian Markets Mixed Amid Cautious Trades

Asian stock markets are mixed on Tuesday, following the positive cues from Wall Street overnight, as traders remain cautious and are reluctant to take major positions ahead of the monetary policy announcements from the European Central Bank, the US Fed and the Bank of Japan this week. Optimism about a potential U.S.-China trade deal and an interest rate cut by the Fed are aiding market sentiment.
RTTNews | 2 ชม. 5 นาทีที่ผ่านมา
Sensex, Nifty To See Muted Start

Sensex, Nifty To See Muted Start

Indian shares look set to open on a muted note Tuesday, tracking mostly weak cues from other Asian markets.
RTTNews | 2 ชม. 27 นาทีที่ผ่านมา
Japanese Market Modestly Lower

Japanese Market Modestly Lower

The Japanese stock market is trading modestly lower on Tuesday, reversing some of the strong gains in the previous session, despite the broadly positive cues from Wall Street overnight. The Nikkei 225 is falling below the 50,400 level, with a mixed performance across most sectors.
RTTNews | 3 ชม. 34 นาทีที่ผ่านมา